Stockreport

Cellectar Bio nabs another Rare Pediatric Disease Designation for CLR 131; shares up 58% premarket [Seeking Alpha]

Cellectar Biosciences, Inc.  (CLRB) 
Last cellectar biosciences, inc. earnings: 11/12 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: investor.cellectar.com
PDF Cellectar Bio nabs another Rare Pediatric Disease Designation for CLR 131; shares up 58% premarketThinly traded nano cap Cellectar Biosciences (NASDAQ:CLRB) is up58% pre [Read more]